Reuters logo
BRIEF-Alnylam says ‍inclisiran phase III development program gearing up​
2017年8月28日 / 下午12点48分 / 1 个月前

BRIEF-Alnylam says ‍inclisiran phase III development program gearing up​

Aug 28 (Reuters) - Alnylam Pharmaceuticals Inc

* New, one-year data from orion-1 phase ii study of inclisiran extends excellent long-term efficacy and safety profile, affirming dose for phase iii trials

* Alnylam pharmaceuticals inc - ‍inclisiran phase iii development program gearing up​ Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below